
  
    
      
        Introduction_NNP
        The_DT synovial_NN tissue_NN in_IN rheumatoid_NN arthritis_NN (_( RA_NNP )_)
        contains_VBZ synovial_NN fibroblasts_NNS and_CC stromal_NN cells_NNS as_RB well_RB as_IN
        macrophages_NNS ._. Synovial_NNP stromal_NN cells_NNS and_CC fibroblasts_NNS are_VBP
        thought_VBN to_TO proliferate_VBP 
        in_IN situ_NN [_NN 1_CD ]_NN ._. On_IN the_DT contrary_NN ,_,
        macrophages_NNS do_VBP not_RB proliferate_VBP ,_, but_CC rather_RB differentiate_VB
        from_IN monocytes_NNS that_IN migrated_JJ from_IN the_DT peripheral_JJ blood_NN ,_, and_CC
        are_VBP activated_VBN to_TO differentiate_VB in_IN the_DT synovial_NN tissue_NN ._.
        Macrophages_NNP in_IN RA_NNP synovium_NN secrete_NN many_JJ inflammatory_JJ
        mediators_NNS (_( IL-_NNP 1_CD ,_, IL-_NNP 6_CD ,_, IL-_NNP 8_CD ,_, tumor_NN necrosis_NNS factor-α_JJ
        [_NN TNF-α_NNP ]_NN and_CC PGE_NNP 
        2_LS )_) and_CC a_DT variety_NN of_IN matrix_NN
        metalloproteinases_NNS ,_, and_CC are_VBP thought_VBN to_TO play_VB a_DT central_JJ role_NN
        in_IN the_DT inflammation_NN and_CC joint_JJ destruction_NN characteristic_NN of_IN
        RA_NNP [_NN 2_CD ]_NN ._. The_DT number_NN of_IN macrophages_NNS in_IN RA_NNP synovium_NN
        correlates_NNS significantly_RB with_IN clinical_JJ symptoms_NNS and_CC the_DT
        degree_NN of_IN joint_JJ damage_NN [_NN 3_CD ]_NN ._. Understanding_NNP the_DT regulation_NN
        of_IN macrophage_NN accumulation_NN in_IN the_DT RA_NNP synovium_NN should_MD
        therefore_RB provide_VB insight_NN into_IN the_DT inflammatory_JJ nature_NN of_IN
        rheumatoid_NN synovitis_NNS ._.
        Migration_NNP of_IN peripheral_JJ blood_NN monocytes_NNS is_VBZ likely_JJ to_TO be_VB
        influenced_VBN by_IN chemokines_NNS ._. A_DT number_NN of_IN chemokines_NNS ,_, including_VBG
        IL-_NNP 8_CD ,_, monocyte_NN chemotactic_JJ protein-_NN 1_CD (_( MCP-_NNP 1_LS )_) ,_, macrophage_NN
        inflammatory_JJ protein-_NN 1_CD α_NN (_( MIP-_NNP 1_CD α_NN )_) ,_, MIP-_NNP 1_CD β_NN ,_,
        epithelial-derived_JJ neutrophil_NN attractant_NN 78_CD ,_, and_CC regulated_VBN
        upon_IN activation_NN ,_, normal_JJ T_NN cell_NN expressed_VBD and_CC secreted_JJ
        (_( RANTES_NNP )_) ,_, are_VBP known_VBN to_TO be_VB found_VBN in_IN RA_NNP synovial_NN fluid_JJ [_NN 4_CD ,_,
        5_CD ,_, 6_CD ,_, 7_CD ,_, 8_CD ]_NN ._. A_DT number_NN of_IN specific_JJ chemokine_NN receptors_NNS
        including_VBG CCR_NNP 1_CD ,_, CCR_NNP 2_CD ,_, CCR_NNP 5_CD ,_, CCR_NNP 8_CD ,_, and_CC CXCR_NNP 4_CD are_VBP also_RB known_VBN
        to_TO be_VB expressed_VBN by_IN peripheral_JJ blood_NN monocytes_NNS [_NN 9_CD ,_, 10_CD ]_NN ._.
        Despite_IN this_DT information_NN ,_, the_DT specific_JJ chemokine-chemokine_JJ
        receptor_NN interactions_NNS involved_VBN in_IN the_DT recruitment_NN of_IN
        monocytes_NNS into_IN the_DT rheumatoid_NN synovium_NN have_VBP not_RB been_VBN fully_RB
        delineated_JJ ._.
        To_TO address_VB this_DT issue_NN ,_, we_PRP examined_VBD chemokine_NN receptor_NN
        expression_NN by_IN peripheral_JJ blood_NN monocytes_NNS ,_, and_CC also_RB analyzed_VBD
        the_DT capacity_NN of_IN supernatants_NNS from_IN RA_NNP synovial_NN stromal_NN cells_NNS
        to_TO induce_VB monocyte_NN migration_NN ._. The_DT data_NNS indicate_VBP that_IN MCP-_NNP 1_CD
        secreted_JJ by_IN synovial_NN stromal_NN cells_NNS plays_VBZ a_DT major_JJ role_NN in_IN
        attracting_VBG monocytes_NNS to_TO the_DT synovium_NN ,_, and_CC that_IN IL-_NNP 8_CD may_MD
        also_RB contribute_VB ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Antibodies_NNP and_CC reagents_NNS
          Biotinylated_NNP mouse_NN anti-human_JJ CCR_NNP 1_CD monoclonal_NN antibody_NN
          (_( mAb_NN )_) ,_, mouse_NN anti-human_JJ CCR_NNP 2_CD mAb_NN conjugated_JJ with_IN
          phycoerythrin_NN (_( PE_NNP )_) ,_, mouse_NN anti-human_JJ CCR_NNP 6_CD mAb_NN conjugated_JJ
          with_IN PE_NNP ,_, mouse_NN anti-human_JJ CXCR_NNP 1_CD mAb_NN conjugated_JJ with_IN PE_NNP ,_,
          mouse_NN anti-human_JJ CXCR_NNP 2_CD mAb_NN conjugated_JJ with_IN PE_NNP ,_, mouse_NN
          anti-human_JJ CXCR_NNP 5_CD mAb_NN conjugated_JJ with_IN PE_NNP ,_, mouse_NN anti-human_JJ
          CCR_NNP 3_CD mAb_NN conjugated_JJ with_IN FITC_NNP ,_, mouse_NN anti-human_JJ MCP-_NNP 1_CD mAb_NN
          (_( 24822_CD ._. 111_CD )_) ,_, mouse_NN anti-human_JJ IL-_NNP 8_CD mAb_NN (_( 6217_CD ._. 111_CD )_) ,_, mouse_NN
          anti-human_JJ IP-_NNP 10_CD mAb_NN (_( 33036_CD ._. 211_CD )_) ,_, mouse_NN anti-human_JJ CCR_NNP 5_CD
          mAb_NN (_( 45531_CD ._. 111_CD )_) ,_, and_CC biotinylated_JJ goat_NN IgG_NNP anti-human_JJ
          IP-_NNP 10_CD were_VBD purchased_VBN from_IN R_NN &_CC D_NNP Systems_NNPS Inc_NNP (_( Miami_NNP ,_,
          FL_NNP )_) ._. Mouse_NNP anti-human_JJ CCR_NNP 5_CD mAb_NN conjugated_JJ with_IN FITC_NNP and_CC
          mouse_NN anti-human_JJ CXCR_NNP 4_CD mAb_NN conjugated_JJ with_IN PE_NNP were_VBD
          purchased_VBN from_IN Pharmingen_NNP (_( San_NNP Diego_NNP ,_, CA_NNP )_) ._. Mouse_NNP
          anti-human_JJ CD_NNP 14_CD mAb_NN conjugated_JJ with_IN FITC_NNP or_CC PE_NNP ,_, and_CC
          Streptavidin_NNP conjugated_JJ with_IN PE_NNP were_VBD obtained_VBN from_IN Sigma_NNP
          (_( St_NNP Louis_NNP ,_, MO_NNP )_) ._. Mouse_NNP IgG_NNP 1_CD mAb_NN was_VBD prepared_VBN from_IN
          hybridoma_NN cell_NN lines_NNS purchased_VBN from_IN ATCC_NNP (_( Rockville_NNP ,_, MD_NNP )_) ._.
          Mouse_NNP IgG_NNP 2_CD A_DT conjugated_JJ with_IN PE_NNP (_( Pharmingen_NNP )_) ,_, mouse_NN IgG_NNP 2_CD B_NNP
          conjugated_JJ with_IN PE_NNP (_( R_NN &_CC D_NNP Systems_NNPS )_) ,_, and_CC mouse_NN IgG_NNP 1_CD
          conjugated_JJ with_IN FITC_NNP (_( Becton_NNP Dickinson_NNP ,_, San_NNP Jose_NNP ,_, CA_NNP )_)
          were_VBD used_VBN for_IN negative_JJ controls_NNS for_IN flow_NN cytometry_NN ._.
          Recombinant_NNP human_JJ TNF-α_NNP ,_, RANTES_NNP ,_, interferon-gamma_JJ
          inducible_JJ protein_NN 10_CD (_( IP-_NNP 10_CD )_) ,_, and_CC stromal_NN cell_NN derived_VBD
          factor-_NN 1_CD α_NN were_VBD purchased_VBN from_IN R_NN &_CC D_NNP Systems_NNPS ._. Trizol_NNP
          reagent_NN ,_, deoxyribonucleaseI_NN ,_, and_CC SuperScriptII_NNP reverse_VB
          transcriptase_NN were_VBD purchased_VBN from_IN Gibco_NNP BRL_NNP (_( Rockville_NNP ,_,
          MD_NNP )_) ._. Taq_NNP polymerase_NN was_VBD purchased_VBN from_IN Promega_NNP (_( Madison_NNP ,_,
          WI_NNP )_) ,_, and_CC Oligo_NNP dT_NN and_CC ficoll_NN /_NN isopaque_NN were_VBD purchased_VBN from_IN
          Pharmacia_NNP (_( Piscataway_NNP ,_, NJ_NNP )_) ._. DMEM_NNP with_IN high-glucose_JJ ,_,
          RPMI-_NNP 1640_CD ,_, and_CC FBS_NNP were_VBD purchased_VBN from_IN Gibco_NNP BRL_NNP ._.
          Enzyme-linked_NNP immunosorbent_NN assays_NNS (_( ELISAs_NNP )_) for_IN MCP-_NNP 1_CD ,_,
          IL-_NNP 8_CD ,_, MIP-_NNP 1_CD β_NN ,_, and_CC RANTES_NNP were_VBD purchased_VBN from_IN R_NN &_CC D_NNP
          Systems_NNPS ,_, and_CC transwell_NN membranes_NNS (_( 5_CD μm_NN pore_NN size_NN in_IN 24_CD
          wells_NNS )_) were_VBD purchased_VBN from_IN Costar_NNP (_( Cambridge_NNP ,_, MA_NNP )_) ._. The_DT
          TMB_NNP microwell_NN peroxidase_NN substrate_NN system_NN was_VBD purchased_VBN
          from_IN KPL_NNP (_( Gaithersburg_NNP ,_, MD_NNP )_) ._.
        
        
          Stromal_NNP cell_NN lines_NNS and_CC fibroblast_NN lines_NNS
          One_CD RA_NNP stromal_NN cell_NN line_NN (_( SCL_NNP )_) was_VBD established_VBN from_IN
          synovium_NN as_RB previously_RB described_VBD [_NN 11_CD ]_NN ._. In_IN brief_JJ ,_,
          synovial_NN tissue_NN of_IN a_DT patient_NN with_IN RA_NNP who_WP met_VBD American_NNP
          College_NNP of_IN Rheumatology_NNP criteria_NNS [_NN 12_CD ]_NN was_VBD obtained_VBN
          following_VBG informed_VBN consent_NN ,_, and_CC dissociated_JJ with_IN
          collagenase_NN and_CC trypsin_NN ._. Dissociated_NNP cells_NNS were_VBD cultured_JJ
          in_IN DMEM_NNP supplemented_JJ with_IN 10_CD %_NN FBS_NNP and_CC 10_CD %_NN conditioned_VBN
          medium_NN ,_, which_WDT was_VBD prepared_VBN by_IN incubation_NN of_IN peripheral_JJ
          blood_NN mononuclear_NN cells_NNS from_IN 10_CD healthy_JJ donors_NNS in_IN
          RPMI-_NNP 1640_CD medium_NN with_IN 10_CD %_NN FBS_NNP for_IN 48_CD h_NN ._. The_DT cultures_NNS were_VBD
          then_RB maintained_VBN for_IN more_JJR than_IN 2_CD months_NNS ,_, and_CC the_DT SCLs_NNP were_VBD
          cloned_VBN by_IN limiting_VBG dilution_NN ._. Clones_NNP were_VBD thereafter_RB
          maintained_VBN and_CC replenished_VBN with_IN fresh_JJ DMEM_NNP medium_NN with_IN 10_CD
          or_CC 20_CD %_NN FBS_NNP every_DT 3_CD -_: 4_CD days_NNS ._. One_CD clone_NN (_( Sy_NNP 77_CD )_) was_VBD used_VBN in_IN
          the_DT present_JJ experiments_NNS ._. RA_NNP tissues_NNS from_IN two_CD other_JJ
          patients_NNS were_VBD also_RB dissociated_JJ with_IN collagenase_NN and_CC
          trypsin_NN ._. Dissociated_NNP cells_NNS were_VBD cultured_JJ in_IN DMEM_NNP
          supplemented_JJ with_IN 10_CD %_NN FBS_NNP and_CC 10_CD %_NN conditioned_VBN medium_NN and_CC
          used_VBN as_IN RA_NNP SCLs_NNP (_( RA_NNP 6_CD /_NN 1_CD and_CC RA_NNP 8_CD /_NN 3_LS )_) after_IN 4_CD -_: 10_CD passages_NNS ._. An_DT
          SCL_NNP was_VBD also_RB established_VBN from_IN osteoarthritis_NNS synovium_NN
          (_( OA_NNP 5_CD /_NN 26_CD )_) using_VBG the_DT same_JJ procedure_NN ._. A_DT skin_NN fibroblast_NN line_NN
          (_( FBHG_NNP )_) was_VBD also_RB established_VBN from_IN a_DT healthy_JJ human_JJ skin_NN
          sample_NN ._.
        
        
          SCL_NNP and_CC fibroblast_NN culture_NN
          RA_NNP SCL_NNP ,_, osteoarthritis_NNS (_( OA_NNP )_) SCL_NNP ,_, and_CC skin_NN fibroblasts_NNS
          (_( 1_CD ×_NN 10_CD 5_LS )_) were_VBD seeded_VBN in_IN six-well_JJ culture_NN plates_NNS
          (_( Costar_NNP )_) with_IN DMEM_NNP containing_VBG 10_CD %_NN FBS_NNP ,_, 200_CD U_NNP /_NN ml_NN
          penicillinG_NN ,_, 10_CD μg_NN /_NN ml_NN gentamicin_NN and_CC 0_CD ._. 3_CD mg_NN /_NN ml_NN
          L-_NNP glutamine_NN ,_, and_CC cultured_JJ for_IN 3_CD days_NNS ._. After_IN culturing_VBG ,_,
          the_DT cells_NNS were_VBD washed_VBN once_RB and_CC the_DT medium_NN was_VBD changed_VBN to_TO
          DMEM_NNP containing_VBG 5_CD %_NN FBS_NNP ,_, 200_CD U_NNP /_NN ml_NN penicillinG_NN ,_, 10_CD μg_NN /_NN ml_NN
          gentamicin_NN ,_, and_CC 0_CD ._. 3_CD mg_NN /_NN ml_NN L-_NNP glutamine_NN with_IN or_CC without_IN 2_CD
          ng_NN /_NN ml_NN TNF-α_NNP ._. To_TO assess_VB chemokine_NN mRNA_NN expression_NN ,_, cell_NN
          lines_NNS were_VBD harvested_VBN after_IN 4_CD h_NN of_IN culture_NN ,_, then_RB suspended_VBN
          in_IN Trizol_NNP and_CC stored_VBD at_IN -_: 80_CD °_NN C_NNP ._. Supernatants_NNP were_VBD
          collected_VBN after_IN 24_CD h_NN and_CC stored_VBD at_IN -_: 80_CD °_NN C_NNP until_IN use_NN for_IN
          migration_NN assay_NN and_CC quantification_NN of_IN chemokines_NNS ._.
        
        
          Preparation_NNP of_IN mononuclear_NN cells_NNS
          Peripheral_NNP blood_NN mononuclear_NN cells_NNS (_( PBMC_NNP )_) were_VBD
          isolated_VBN from_IN heparinized_JJ blood_NN of_IN healthy_JJ adult_NN
          volunteers_NNS by_IN density_NN sedimentation_NN using_VBG
          ficoll_NN /_NN isopaque_NN ._. PBMC_NNP were_VBD cultured_JJ with_IN sheep_NN red_JJ blood_NN
          cells_NNS (_( SRBC_NNP )_) treated_VBN for_IN 70_CD min_NN at_IN 4_CD °_NN C_NNP ,_, and_CC rosette_NN
          negative_JJ cells_NNS were_VBD collected_VBN by_IN ficoll_NN /_NN isopaque_NN
          sedimentation_NN ._.
        
        
          Chemokine_NNP receptor_NN expression_NN by_IN monocytes_NNS
          Chemokine_NNP receptor_NN expression_NN by_IN monocytes_NNS was_VBD
          assessed_VBN by_IN dual_JJ immunofluorescence_NN flow_NN cytometry_NN
          following_VBG staining_VBG with_IN anti-_NN CD_NNP 14_CD mAb_NN and_CC anti-chemokine_JJ
          receptor_NN mAbs_NNS (_( FACScan_NNP ;_: Becton_NNP Dickinson_NNP )_) ._. For_IN staining_VBG
          chemokine_NN receptors_NNS ,_, 10_CD μl_NN of_IN each_DT mAb_NN was_VBD used_VBN for_IN 1_CD ×_NN
          10_CD 5_CD cells_NNS suspended_VBN in_IN 100_CD μl_NN staining_VBG buffer_NN (_( PBS_NNP +_NN 2_CD %_NN
          FBS_NNP )_) in_IN accordance_NN with_IN the_DT manufacturer_NN 's_POS
          instructions_NNS ._.
        
        
          Migration_NNP assay_NN
          Cell_NNP migration_NN was_VBD assessed_VBN in_IN 24_CD -_: well_RB chemotaxis_NNS
          chambers_NNS fitted_JJ with_IN 5_CD ._. 0_CD μm_NN transwell_NN membranes_NNS ._.
          Supernatants_NNP (_( 550_CD μl_NN )_) of_IN cell_NN lines_NNS cultured_JJ in_IN various_JJ
          conditions_NNS were_VBD added_VBN to_TO the_DT lower_JJR wells_NNS ,_, and_CC 5_CD ×_NN 10_CD
          5_CD SRBC_NNP rosette_NN negative_JJ PBMC_NNP in_IN 100_CD μl_NN DMEM_NNP containing_VBG 5_CD %_NN
          FBS_NNP were_VBD added_VBN to_TO the_DT upper_JJ wells_NNS ._. In_IN blocking_VBG
          experiments_NNS ,_, the_DT supernatants_NNS were_VBD cultured_JJ with_IN blocking_VBG
          mAbs_NNS specific_JJ for_IN chemokines_NNS overnight_JJ at_IN 4_CD °_NN C_NNP before_IN
          assay_NN ._. SRBC_NNP rosette_NN negative_JJ PBMC_NNP were_VBD incubated_JJ with_IN
          blocking_VBG mAb_NN to_TO chemokine_NN receptors_NNS for_IN 1_CD h_NN at_IN 4_CD °_NN C_NNP before_IN
          assay_NN in_IN some_DT experiments_NNS ._. The_DT transwell_NN membranes_NNS were_VBD
          removed_VBN after_IN 90_CD min_NN of_IN incubation_NN at_IN 37_CD °_NN C_NNP ,_, and_CC migrated_JJ
          cells_NNS in_IN the_DT lower_JJR chamber_NN were_VBD harvested_VBN by_IN pipetting_VBG ._.
          The_DT cells_NNS were_VBD stained_JJ with_IN anti-_NN CD_NNP 14_CD mAb_NN conjugated_JJ with_IN
          FITC_NNP ,_, and_CC they_PRP were_VBD suspended_VBN in_IN 110_CD μl_NN PBS_NNP containing_VBG 3_CD %_NN
          FBS_NNP ._. All_DT of_IN the_DT cells_NNS were_VBD analyzed_VBN by_IN flow_NN cytometry_NN and_CC
          CD_NNP 14_CD +_NN cells_NNS were_VBD counted_VBN ._.
        
        
          RNA_NNP isolation_NN and_CC reverse_VB transcriptase-polymerase_JJ
          chain_NN reaction_NN
          RNA_NNP was_VBD extracted_VBN from_IN SCLs_NNP and_CC fibroblasts_NNS using_VBG
          Trizol_NNP reagent_NN in_IN accordance_NN with_IN the_DT manufacturer_NN 's_POS
          instructions_NNS ._. Two_CD micrograms_NNS of_IN the_DT extracted_VBN RNA_NNP was_VBD
          treated_VBN with_IN 2_CD U_NNP DNaseI_NNP to_TO eliminate_VB DNA_NNP ,_, and_CC reverse_VB
          transcribed_JJ with_IN 200_CD U_NNP SuperScriptII_NNP reverse_VB
          transcriptase_NN at_IN 42_CD °_NN C_NNP for_IN 70_CD min_NN using_VBG oligo_NN dT_NN primers_NNS
          in_IN accordance_NN with_IN the_DT manufacturer_NN 's_POS instructions_NNS ._.
          Polymerase_NNP chain_NN reaction_NN (_( PCR_NNP )_) was_VBD carried_VBN out_IN with_IN Taq_NNP
          polymerase_NN using_VBG 0_CD ._. 1_CD -_: 0_CD ._. 3_LS μl_NN cDNA_NN (_( 1_CD ._. 5_LS mM_NN MgCl_NNP 
          2_LS )_) ._. Denaturation_NNP and_CC extension_NN
          conditions_NNS were_VBD 94_CD °_NN C_NNP for_IN 1_CD min_NN and_CC 72_CD °_NN C_NNP for_IN 1_CD min_NN ,_,
          respectively_RB ._. The_DT annealing_VBG period_NN was_VBD 1_CD min_NN for_IN each_DT
          PCR_NNP ,_, and_CC the_DT temperature_NN was_VBD 62_CD °_NN C_NNP for_IN RANTES_NNP and_CC 56_CD °_NN C_NNP for_IN
          the_DT other_JJ chemokines_NNS and_CC β-actin_JJ ._. PCR_NNP products_NNS were_VBD
          resolved_VBN by_IN electrophoresis_NNS on_IN 1_CD ._. 5_CD %_NN agarose_NN gels_NNS and_CC
          identified_VBN with_IN ethidium_NN bromide_NN staining_VBG ._. Firstly_NNP ,_,
          β-actin_JJ expression_NN was_VBD examined_VBN using_VBG 26_CD -_: 30_CD cycles_NNS of_IN
          reverse_NN transcriptase-_NN PCR_NNP (_( RT-PCR_NNP )_) to_TO amplify_VB 0_CD ._. 1_CD ,_, 0_CD ._. 2_CD ,_,
          and_CC 0_CD ._. 3_CD μl_NN cDNA_NN to_TO adjust_VB the_DT amount_NN of_IN cDNA_NN of_IN each_DT
          sample_NN precisely_RB ._. After_IN resolving_VBG the_DT PCR_NNP products_NNS on_IN
          agarose_NN gels_NNS and_CC identifying_VBG the_DT relevant_JJ bands_NNS with_IN
          ethidium_NN bromide_NN ,_, the_DT optimal_NN amounts_NNS of_IN cDNA_NN for_IN
          analysis_NN were_VBD then_RB determined_VBN ._. Chemokine_NNP expression_NN in_IN
          this_DT amount_NN of_IN cDNA_NN was_VBD examined_VBN using_VBG 30_CD ,_, 32_CD ,_, 35_CD ,_, 38_CD ,_,
          and_CC 40_CD cycles_NNS of_IN PCR_NNP amplification_NN ,_, and_CC the_DT results_NNS in_IN
          the_DT linear_JJ part_NN of_IN the_DT amplification_NN curve_NN are_VBP reported_VBN
          in_IN the_DT figures_NNS ._.
        
        
          PCR_NNP primers_NNS
          The_DT primer_NN pair_NN for_IN β-actin_JJ was_VBD GTC_NNP CTC_NNP TCC_NNP CAA_NNP GTC_NNP
          CAC_NNP ACA_NNP (_( forward_RB )_) and_CC CTG_NNP GTC_NNP TCA_NNP AGT_NNP CAG_NNP TGT_NNP ACA_NNP GGT_NNP AA_NN
          (_( reverse_VB )_) ,_, that_IN of_IN IL-_NNP 8_CD was_VBD CTG_NNP CGC_NNP CAA_NNP CAC_NNP AGA_NNP AAT_NNP TA_NNP
          (_( forward_RB )_) and_CC ATT_NNP GCA_NNP TCT_NNP GGC_NNP AAC_NNP CCT_NNP AC_NNP (_( reverse_VB )_) ,_, that_IN
          of_IN MCP-_NNP 1_CD was_VBD GCC_NNP TCC_NNP AGC_NNP ATG_NNP AAA_NNP GTC_NNP TC_NNP (_( forward_RB )_) and_CC TAA_NNP
          AAC_NNP AGG_NNP GTG_NNP TCT_NNP GGG_NNP GA_NNP (_( reverse_VB )_) ,_, that_IN of_IN IP-_NNP 10_CD was_VBD CCA_NNP
          CGT_NNP GTT_NNP GAG_NNP ATC_NNP ATT_NNP GC_NNP (_( forward_RB )_) and_CC TGG_NNP AAG_NNP ATG_NNP GGA_NNP AAG_NNP
          GTG_NNP AG_NNP (_( reverse_VB )_) ,_, that_IN of_IN RANTES_NNP was_VBD CGC_NNP TGT_NNP CAT_NNP CCT_NNP CAT_NNP
          TGC_NNP TA_NNP (_( forward_RB )_) and_CC GCT_NNP GTC_NNP TCG_NNP AAC_NNP TCC_NNP TGA_NNP CC_NNP
          (_( reverse_VB )_) ,_, that_IN of_IN MIP-_NNP 1_CD α_NN was_VBD TGC_NNP AAC_NNP CAG_NNP TTC_NNP TCT_NNP GCA_NNP TC_NNP
          (_( forward_RB )_) and_CC ACA_NNP GGG_NNP GAA_NNP CTC_NNP TCA_NNP GAG_NNP CA_NNP (_( reverse_VB )_) ,_, and_CC
          that_IN of_IN MIP-_NNP 1_CD β_NN was_VBD CTG_NNP GGT_NNP CCA_NNP GGA_NNP GTA_NNP CGT_NNP GT_NNP (_( forward_RB )_)
          and_CC ACA_NNP GTG_NNP GAC_NNP CAT_NNP CCC_NNP CAT_NNP AG_NNP (_( reverse_VB )_) ._.
        
        
          ELISA_NNP
          Concentrations_NNP of_IN chemokines_NNS were_VBD measured_VBN by_IN sandwich_NN
          ELISA_NNP according_VBG to_TO the_DT manufacturer_NN 's_POS instructions_NNS
          (_( R_NN &_CC D_NNP Systems_NNPS )_) ._.
        
        
          Statistical_NNP analysis_NN
          The_DT Student_NNP paired_VBN 
          t_NN test_NN was_VBD used_VBN to_TO compare_VB the_DT
          effect_NN of_IN CD_NNP 14_CD cell_NN migration_NN ,_, and_CC the_DT blocking_VBG effect_NN of_IN
          mAbs_NNS ._. The_DT Student_NNP 
          t_NN test_NN was_VBD used_VBN to_TO evaluate_VB
          chemokine_NN production_NN by_IN SCLs_NNP and_CC the_DT fibroblast_NN line_NN ._.
        
      
      
        Results_NNS
        
          Chemokine_NNP receptor_NN expression_NN by_IN peripheral_JJ blood_NN
          monocytes_NNS
          Chemokine_NNP receptor_NN expression_NN by_IN CD_NNP 14_CD +_NN monocytes_NNS was_VBD
          examined_VBN using_VBG flow_NN cytometry_NN ._. Representative_NNP examples_NNS
          (_( Fig_NNP ._. 1_LS )_) and_CC asummary_JJ of_IN staining_VBG results_NNS (_( Table_NNP 1_LS )_) are_VBP
          presented_VBN ._. CXCR_NNP 3_CD and_CC CXCR_NNP 4_CD were_VBD expressed_VBN by_IN a_DT high_JJ
          frequency_NN of_IN monocytes_NNS in_IN all_DT healthy_JJ donors_NNS ._. More_JJR than_IN
          one-half_NN of_IN monocytes_NNS expressed_VBD CCR_NNP 2_CD ,_, CCR_NNP 5_CD ,_, CXCR_NNP 1_CD ,_, and_CC
          CXCR_NNP 2_CD in_IN seven_CD of_IN nine_CD cases_NNS ,_, although_IN a_DT minimal_JJ number_NN
          of_IN monocytes_NNS from_IN two_CD donors_NNS expressed_VBD these_DT receptors_NNS ._.
          Expression_NNP of_IN CCR_NNP 6_CD and_CC CXCR_NNP 5_CD by_IN monocytes_NNS was_VBD minimal_JJ in_IN
          all_DT subjects_NNS ._. CCR_NNP 1_CD was_VBD expressed_VBN by_IN few_JJ monocytes_NNS in_IN
          three_CD donors_NNS ,_, whereas_IN 20_CD -_: 40_CD %_NN of_IN monocytes_NNS of_IN the_DT other_JJ
          donors_NNS expressed_VBD CCR_NNP 1_CD ._. These_DT results_NNS suggest_VBP that_IN CCR_NNP 1_CD ,_,
          CCR_NNP 2_CD ,_, CCR_NNP 5_CD ,_, and_CC CXCR_NNP 1_CD ,_, CXCR_NNP 2_CD ,_, CXCR_NNP 3_CD ,_, and_CC CXCR_NNP 4_CD are_VBP
          candidates_NNS to_TO be_VB involved_VBN in_IN chemokine-mediated_JJ
          trafficking_NN of_IN monocytes_NNS ._.
        
        
          Supernatants_NNP of_IN cell_NN lines_NNS attract_VBP monocytes_NNS
          To_TO examine_VB whether_IN SCLs_NNP derived_VBD from_IN RA_NNP synovium_NN can_MD
          attract_VB monocytes_NNS efficiently_RB ,_, migration_NN of_IN monocytes_NNS in_IN
          response_NN to_TO culture_NN supernatants_NNS of_IN RA_NNP and_CC OA_NNP SCLs_NNP and_CC
          fibroblasts_NNS was_VBD examined_VBN (_( Fig_NNP ._. 2_LS )_) ._. Supernatants_NNP of_IN all_DT
          cell_NN lines_NNS attracted_VBD significantly_RB more_JJR monocytes_NNS than_IN
          medium_NN alone_RB (_( 
          P_NN <_NN 0_CD ._. 01_CD )_) ._. Those_DT supernatants_NNS
          from_IN RA_NNP SCLs_NNP induced_VBD the_DT migration_NN of_IN significantly_RB more_JJR
          monocytes_NNS than_IN the_DT supernatants_NNS of_IN the_DT OA_NNP SCL_NNP and_CC skin_NN
          fibroblasts_NNS ._.
        
        
          Chemokine_NNP mRNA_NN production_NN by_IN cell_NN lines_NNS
          Production_NN of_IN proinflammatory_NN chemokine_NN mRNA_NN by_IN the_DT
          various_JJ cell_NN lines_NNS was_VBD assessed_VBN using_VBG RT-PCR_NNP (_( Fig_NNP ._. 3_LS )_) ._. RA_NNP
          SCLs_NNP expressed_VBD a_DT number_NN of_IN proinflammatory_NN chemokine_NN
          mRNAs_NNS ,_, including_VBG MCP-_NNP 1_CD ,_, IL-_NNP 8_CD ,_, MIP-_NNP 1_CD α_NN ,_, MIP-_NNP 1_CD β_NN ,_, RANTES_NNP ,_, and_CC
          IP-_NNP 10_CD ._. OA_NNP SCL_NNP also_RB expressed_VBD these_DT same_JJ chemokine_NN mRNAs_NNS
          with_IN the_DT exception_NN of_IN MIP-_NNP 1_CD β_NN ._. The_DT fibroblast_NN line_NN
          expressed_VBD mRNAs_NNS for_IN IL-_NNP 8_CD ,_, MCP-_NNP 1_CD ,_, and_CC IP-_NNP 10_CD ,_, but_CC not_RB
          RANTES_NNP ,_, MIP-_NNP 1_CD α_NN ,_, and_CC MIP-_NNP 1_CD β_NN ._.
        
        
          Chemokine_NNP production_NN by_IN cell_NN lines_NNS
          Chemokines_NNP secreted_JJ into_IN the_DT culture_NN supernatants_NNS of_IN
          cell_NN lines_NNS were_VBD measured_VBN by_IN ELISA_NNP (_( Fig_NNP ._. 4_LS )_) ._. Production_NN of_IN
          MCP-_NNP 1_CD and_CC IL-_NNP 8_CD by_IN RA_NNP SCLs_NNP was_VBD greater_JJR than_IN that_DT by_IN OA_NNP SCL_NNP
          and_CC the_DT fibroblast_NN line_NN ._. The_DT cell_NN lines_NNS produced_VBD low_JJ
          levels_NNS of_IN RANTES_NNP ,_, whereas_IN IP-_NNP 10_CD and_CC MIP_NNP 1_CD -_: β_NN were_VBD not_RB
          detected_VBN (_( data_NNS not_RB shown_VBN )_) ._.
        
        
          MCP-_NNP 1_CD and_CC IL-_NNP 8_CD play_VB a_DT role_NN in_IN migration_NN of_IN
          monocytes_NNS
          Blocking_NNP experiments_NNS were_VBD carried_VBN out_IN using_VBG mAbs_NNS to_TO
          determine_VB the_DT chemokines_NNS that_WDT contribute_VBP to_TO monocyte_NN
          migration_NN induced_VBN by_IN RA_NNP SCLs_NNP (_( Fig_NNP ._. 5_LS )_) ._. Anti-_NNP MCP-_NNP 1_CD and_CC
          anti-_NN IL-_NNP 8_CD mAbs_NNS decreased_VBD monocyte_NN migration_NN
          significantly_RB ,_, with_IN the_DT effect_NN of_IN anti-_NN MCP-_NNP 1_CD being_VBG
          consistently_RB greater_JJR than_IN that_DT of_IN anti-_NN IL-_NNP 8_CD ._. Anti-_NNP CCR_NNP 5_CD
          blocking_VBG mAb_NN did_VBD not_RB effect_VB monocyte_NN migration_NN ._. The_DT
          anti-_NN CCR_NNP 5_CD mAb_NN did_VBD have_VB blocking_VBG activity_NN ,_, however_RB ,_, since_IN
          migration_NN of_IN T_NN cells_NNS induced_VBN by_IN RANTES_NNP (_( 500_CD ng_NN /_NN ml_NN )_) was_VBD
          blocked_VBN by_IN 95_CD %_NN (_( data_NNS not_RB shown_VBN )_) ._.
        
        
          Stimulation_NNP with_IN TNF-α_NNP induces_VBZ RA_NNP SCL_NNP to_TO produce_VB
          more_JJR chemokines_NNS and_CC attract_VB more_JJR monocytes_NNS
          RA_NNP SCLs_NNP were_VBD stimulated_VBN with_IN TNF-α_NNP ,_, and_CC chemokine_NN
          production_NN and_CC the_DT capacity_NN of_IN supernatants_NNS to_TO influence_VB
          monocyte_NN migration_NN were_VBD examined_VBN to_TO assess_VB the_DT influence_NN
          of_IN inflammatory_JJ cytokines_NNS on_IN chemokine_NN production_NN and_CC
          monocyte_NN trafficking_NN ._. Supernatants_NNP from_IN RA_NNP SCLs_NNP
          stimulated_VBN with_IN 2_CD ng_NN /_NN ml_NN TNF-α_NNP produced_VBD more_JJR MCP-_NNP 1_CD ,_, IL-_NNP 8_CD ,_,
          RANTES_NNP and_CC IP-_NNP 10_CD (_( Fig_NNP ._. 6_CD )_) ,_, and_CC attracted_VBD more_JJR monocytes_NNS
          (_( Fig_NNP ._. 7_CD )_) than_IN those_DT that_WDT were_VBD unstimulated_JJ ._.
        
        
          MCP-_NNP 1_CD and_CC IL-_NNP 8_CD play_VB major_JJ roles_NNS in_IN monocyte_NN
          migration_NN by_IN RA_NNP SCLs_NNP after_IN TNF-α_NNP stimulation_NN
          Anti-_NNP MCP-_NNP 1_CD mAb_NN and_CC anti-_NN IL-_NNP 8_CD mAb_NN significantly_RB
          inhibited_VBD monocyte_NN migration_NN by_IN supernatants_NNS of_IN RA_NNP SCLs_NNP
          stimulated_VBN with_IN TNF-α_NNP ._. Anti-_NNP IP-_NNP 10_CD mAb_NN and_CC anti-_NN CCR_NNP 5_CD mAb_NN
          did_VBD not_RB inhibit_VB monocyte_NN migration_NN significantly_RB (_( Fig_NNP ._.
          8_CD )_) ._.
        
      
      
        Discussion_NNP
        The_DT results_NNS of_IN this_DT study_NN indicate_VBP that_IN supernatants_NNS of_IN
        SCL_NNP derived_VBD from_IN RA_NNP synovial_NN tissue_NN can_MD attract_VB more_JJR
        monocytes_NNS from_IN peripheral_JJ blood_NN than_IN OA_NNP SCL_NNP and_CC skin_NN
        fibroblasts_NNS ._. MCP-_NNP 1_CD and_CC ,_, to_TO a_DT lesser_JJR degree_NN ,_, IL-_NNP 8_CD played_VBD the_DT
        major_JJ roles_NNS in_IN SCL-induced_NNP trafficking_NN of_IN monocytes_NNS ._. These_DT
        results_NNS begin_VBP to_TO provide_VB an_DT explanation_NN for_IN the_DT extensive_JJ
        accumulation_NN of_IN myeloid_NN cells_NNS in_IN rheumatoid_NN synovium_NN ._.
        Importantly_NNP ,_, RA_NNP SCL_NNP induced_VBD more_JJR monocyte_NN migration_NN after_IN
        stimulation_NN with_IN TNF-α_NNP ,_, one_CD of_IN the_DT major_JJ inflammatory_JJ
        cytokines_NNS produced_VBN in_IN the_DT rheumatoid_NN synovium_NN ._.
        Peripheral_NNP blood_NN monocytes_NNS express_VBP many_JJ chemokine_NN
        receptors_NNS [_NN 9_CD ,_, 10_CD ]_NN ,_, including_VBG CCR_NNP 1_CD ,_, CCR_NNP 2_CD ,_, CCR_NNP 5_CD ,_, CCR_NNP 8_CD ,_, and_CC
        CXCR_NNP 4_CD ._. The_DT current_JJ analysis_NN indicates_VBZ that_IN ,_, along_IN with_IN
        these_DT receptors_NNS ,_, CXCR_NNP 1_CD ,_, CXCR_NNP 2_CD ,_, and_CC CXCR_NNP 3_CD are_VBP also_RB expressed_VBN
        by_IN monocytes_NNS ._. CCR_NNP 1_CD ,_, CCR_NNP 2_CD ,_, CCR_NNP 5_CD ,_, CXCR_NNP 1_CD ,_, CXCR_NNP 2_CD ,_, CXCR_NNP 3_CD ,_, and_CC
        CXCR_NNP 4_CD notably_RB appear_VB to_TO be_VB expressed_VBN by_IN monocytes_NNS obtained_VBN
        from_IN most_JJS donors_NNS ._.
        Ligands_NNP of_IN these_DT chemokine_NN receptors_NNS are_VBP candidates_NNS to_TO
        be_VB involved_VBN in_IN monocyte_NN trafficking_NN ._. These_DT ligands_NNS would_MD
        include_VB RANTES_NNP ,_, MIP-_NNP 1_CD α_NN and_CC MCP-_NNP 3_CD (_( CCR_NNP 1_LS )_) ,_, MCP-_NNP 1_CD ,_, MCP-_NNP 2_CD ,_,
        MCP-_NNP 3_CD ,_, MCP-_NNP 4_CD ,_, MCP-_NNP 5_CD (_( CCR_NNP 2_LS )_) ,_, RANTES_NNP ,_, MIP-_NNP 1_CD α_NN ,_, and_CC MIP-_NNP 1_CD β_NN
        (_( CCR_NNP 5_LS )_) ,_, IL-_NNP 8_CD and_CC CGP-_NNP 2_CD (_( CXCR_NNP 1_LS )_) ,_, IL-_NNP 8_CD ,_, GROα_NNP ,_, and_CC
        epithelial-derived_JJ neutrophil_NN attractant_NN 78_CD (_( CXCR_NNP 2_LS )_) ,_, IP-_NNP 10_CD
        and_CC MIG_NNP (_( CXCR_NNP 3_LS )_) ,_, and_CC stromal_NN cell_NN derived_VBD factor-_NN 1_CD (_( CXCR_NNP 4_LS )_)
        [_NN 13_CD ]_NN ._. Migration_NNP assays_NNS using_VBG supernatants_NNS of_IN RA_NNP SCLs_NNP were_VBD
        employed_VBN to_TO determine_VB which_WDT of_IN these_DT chemokine_NN and_CC receptor_NN
        interactions_NNS might_MD be_VB involved_VBN in_IN monocyte_NN migration_NN in_IN the_DT
        RA_NNP synovium_NN ._.
        Stromal_NNP cells_NNS are_VBP one_CD of_IN the_DT important_JJ cell_NN populations_NNS
        in_IN RA_NNP synovium_NN ._. SCL_NNP can_MD produce_VB many_JJ cytokines_NNS ,_, chemokines_NNS ,_,
        and_CC can_MD promote_VB viability_NN and_CC functional_JJ activation_NN of_IN T_NN
        cells_NNS and_CC B_NNP cells_NNS [_NN 14_CD ,_, 15_CD ,_, 16_CD ]_NN ._. The_DT current_JJ findings_NNS also_RB
        indicate_VBP that_IN supernatants_NNS of_IN RA_NNP SCLs_NNP attract_VB more_JJR
        monocytes_NNS than_IN the_DT supernatants_NNS of_IN OA_NNP SCL_NNP and_CC skin_NN
        fibroblasts_NNS ._. This_DT result_NN suggests_VBZ that_IN the_DT supernatants_NNS
        from_IN RA_NNP SCLs_NNP may_MD contain_VB more_JJR chemokines_NNS than_IN or_CC different_JJ
        chemokines_NNS to_TO those_DT of_IN OA_NNP SCL_NNP or_CC fibroblast_NN lines_NNS and_CC ,_,
        therefore_RB ,_, are_VBP able_JJ to_TO attract_VB additional_JJ monocytes_NNS ._. This_DT
        is_VBZ likely_JJ to_TO contribute_VB to_TO the_DT more_JJR marked_VBD accumulation_NN of_IN
        monocytes_NNS in_IN RA_NNP compared_VBD with_IN OA_NNP synovium_NN ._.
        An_DT analysis_NN of_IN chemokines_NNS produced_VBN by_IN RA_NNP SCL_NNP indicated_VBD
        that_IN these_DT cells_NNS expressed_VBD MCP-_NNP 1_CD and_CC IL-_NNP 8_CD mRNAs_NNS ,_, and_CC also_RB
        secreted_JJ MCP-_NNP 1_CD and_CC IL-_NNP 8_CD ._. It_PRP is_VBZ noteworthy_JJ that_IN there_EX were_VBD
        some_DT discrepancies_NNS between_IN mRNA_NN expression_NN and_CC protein_NN
        production_NN ._. From_IN the_DT mRNA_NN expression_NN ,_, we_PRP expected_VBD RA_NNP SCLs_NNP
        to_TO produce_VB reasonable_JJ amounts_NNS of_IN IP-_NNP 10_CD ,_, RANTES_NNP ,_, MIP-_NNP 1_CD α_NN ,_, and_CC
        MIP-_NNP 1_CD β_NN ._. RA_NNP SCLs_NNP ,_, however_RB ,_, secreted_JJ only_RB small_JJ amounts_NNS of_IN
        RANTES_NNP ,_, and_CC IP-_NNP 10_CD and_CC MIP-_NNP 1_CD β_NN secretion_NN was_VBD not_RB detected_VBN ._.
        According_VBG to_TO previous_JJ reports_NNS ,_, mRNAs_NNS of_IN MCP-_NNP 1_CD ,_, IL-_NNP 8_CD ,_, and_CC
        RANTES_NNP were_VBD found_VBN in_IN RA_NNP SCL_NNP or_CC fibroblasts_NNS ,_, but_CC only_RB MCP-_NNP 1_CD
        was_VBD reported_VBN to_TO be_VB secreted_JJ by_IN RA_NNP SCL_NNP or_CC fibroblasts_NNS
        without_IN cytokine_NN stimulation_NN [_NN 4_CD ,_, 5_CD ,_, 17_CD ,_, 18_CD ]_NN ._. The_DT current_JJ
        study_NN indicates_VBZ a_DT wider_JJR profile_NN of_IN chemokine_NN expression_NN and_CC
        secretion_NN by_IN RA_NNP SCL_NNP ,_, and_CC also_RB a_DT greater_JJR production_NN of_IN IL-_NNP 8_CD
        and_CC MCP-_NNP 1_CD by_IN RA_NNP SCL_NNP compared_VBD with_IN OA_NNP SCL_NNP ,_, implying_VBG a_DT
        greater_JJR proinflammatory_NN potential_JJ ._.
        Experiments_NNS with_IN blocking_VBG mAbs_NNS were_VBD carried_VBN out_IN to_TO
        examine_VB the_DT chemokines_NNS in_IN the_DT supernatants_NNS of_IN SCL_NNP that_WDT
        accounted_VBD for_IN monocyte_NN migration_NN ._. The_DT data_NNS were_VBD consistent_JJ
        with_IN the_DT conclusion_NN that_IN MCP-_NNP 1_CD and_CC ,_, to_TO a_DT lesser_JJR extent_NN ,_,
        IL-_NNP 8_CD accounted_VBD for_IN the_DT capacity_NN of_IN RA_NNP SCL_NNP supernatants_NNS to_TO
        stimulate_VB monocyte_NN migration_NN ._. Whether_IN additional_JJ cytokines_NNS
        produced_VBN by_IN RA_NNP SCL_NNP also_RB contributed_VBD to_TO monocyte_NN migration_NN
        is_VBZ currently_RB not_RB known_VBN ,_, but_CC the_DT combination_NN of_IN the_DT
        chemokine_NN data_NN and_CC the_DT mAb_NN blocking_VBG results_NNS suggests_VBZ that_IN
        MCP-_NNP 1_CD and_CC IL-_NNP 8_CD play_VB a_DT dominant_JJ role_NN in_IN monocyte_NN migration_NN
        measured_VBN by_IN SCL_NNP ._.
        TNF-α_NNP is_VBZ one_CD of_IN the_DT major_JJ cytokines_NNS produced_VBN in_IN
        inflammatory_JJ sites_NNS such_JJ as_IN RA_NNP synovium_NN ,_, and_CC it_PRP is_VBZ thought_VBN
        to_TO play_VB a_DT central_JJ proinflammatory_NN role_NN [_NN 2_CD ]_NN ._. We_PRP examined_VBD
        the_DT influence_NN of_IN TNF-α_NNP on_IN monocyte_NN migration_NN induced_VBN by_IN RA_NNP
        SCL_NNP ._. RA_NNP SCLs_NNP stimulated_VBN by_IN TNF-α_NNP secreted_JJ more_JJR MCP-_NNP 1_CD ,_, IL-_NNP 8_CD ,_,
        and_CC RANTES_NNP than_IN those_DT that_WDT were_VBD unstimulated_JJ ,_, and_CC began_VBD to_TO
        produce_VB IP-_NNP 10_CD ._. Moreover_RB ,_, supernatants_NNS of_IN TNF-α-stimulated_NNP
        RA_NNP SCLs_NNP attracted_VBD more_JJR monocytes_NNS in_IN migration_NN assay_NN ._. MCP-_NNP 1_CD
        and_CC IL-_NNP 8_CD played_VBD the_DT main_JJ roles_NNS in_IN monocyte_NN migration_NN
        induced_VBN by_IN TNF-α-stimulated_NNP RA-SCL_NNP ,_, as_IN documented_VBN by_IN
        blocking_VBG experiments_NNS ._.
        It_PRP has_VBZ recently_RB been_VBN reported_VBN that_IN T_NN cells_NNS expressing_VBG
        CCR_NNP 5_CD gather_VB at_IN inflammatory_JJ sites_NNS such_JJ as_IN RA_NNP or_CC multiple_JJ
        sclerosis_NN ,_, and_CC that_IN interactions_NNS between_IN CCR_NNP 5_CD and_CC its_PRP$
        ligands_NNS (_( RANTES_NNP ,_, MIP-_NNP 1_CD α_NN ,_, MIP-_NNP 1_CD β_NN )_) are_VBP thought_VBN to_TO be_VB
        important_JJ in_IN the_DT accumulation_NN of_IN inflammatory_JJ cells_NNS at_IN
        these_DT sites_NNS [_NN 19_CD ,_, 20_CD ,_, 21_CD ]_NN ._. CCR_NNP 5_CD expressed_VBN by_IN monocytes_NNS ,_,
        however_RB ,_, was_VBD not_RB apparently_RB active_JJ in_IN transmitting_VBG
        transmigratory_NN signals_NNS ._. RANTES_NNP is_VBZ also_RB the_DT ligand_NN of_IN CCR_NNP 1_CD ,_,
        but_CC the_DT major_JJ receptor_NN for_IN RANTES_NNP is_VBZ thought_VBN to_TO be_VB CCR_NNP 5_CD ._. In_IN
        this_DT regard_NN ,_, expression_NN of_IN CCR_NNP 1_CD by_IN monocytes_NNS was_VBD lower_JJR than_IN
        that_DT of_IN CCR_NNP 5_CD ._. Moreover_RB ,_, antibody_NN to_TO MCP-_NNP 1_CD and_CC IL-_NNP 8_CD blocked_VBN
        75_CD %_NN and_CC 20_CD %_NN of_IN migration_NN of_IN monocytes_NNS ,_, respectively_RB ._.
        According_VBG to_TO this_DT information_NN ,_, RANTES_NNP is_VBZ unlikely_JJ to_TO play_VB a_DT
        major_JJ role_NN in_IN monocyte_NN migration_NN by_IN RA_NNP SCL_NNP
        supernatants_NNS ._.
        MCP-_NNP 1_CD has_VBZ been_VBN shown_VBN to_TO play_VB an_DT important_JJ role_NN in_IN the_DT
        development_NN of_IN arthritis_NN in_IN MRL-lpr_NNP mice_NNS [_NN 22_CD ]_NN ,_, whereas_IN the_DT
        migration_NN of_IN monocytes_NNS into_IN inflammatory_JJ sites_NNS was_VBD reduced_VBN
        in_IN the_DT CCR_NNP 2_CD -_: deficient_NN mouse_NN [_NN 23_CD ]_NN ._. These_DT results_NNS are_VBP
        consistent_JJ with_IN the_DT current_JJ findings_NNS ,_, demonstrating_VBG the_DT
        important_JJ role_NN of_IN MCP-_NNP 1_CD in_IN monocyte_NN migration_NN ._. Blocking_NNP the_DT
        effect_NN of_IN RANTES_NNP has_VBZ ,_, however_RB ,_, also_RB been_VBN shown_VBN to_TO be_VB
        effective_JJ in_IN ameliorating_VBG collagen-induced_JJ arthritis_NN in_IN
        DAB_NNP /_NN 1_CD mice_NNS and_CC adjuvant-induced_JJ arthritis_NN in_IN rats_NNS [_NN 24_CD ,_,
        25_CD ]_NN ._. RANTES_NNP might_MD ,_, therefore_RB ,_, play_VBP a_DT different_JJ role_NN in_IN the_DT
        initiation_NN of_IN inflammatory_JJ arthritis_NN in_IN experimental_JJ
        animals_NNS compared_VBN with_IN propagating_VBG chronic_JJ inflammation_NN in_IN
        RA_NNP ._.
        The_DT overlapping_VBG roles_NNS of_IN MCP-_NNP 1_CD and_CC IL-_NNP 8_CD in_IN the_DT migration_NN
        of_IN inflammatory_JJ cells_NNS have_VBP recently_RB been_VBN highlighted_VBN in_IN
        studies_NNS of_IN neutrophil_NN trafficking_NN ._. It_PRP was_VBD reported_VBN that_IN
        MCP-_NNP 1_CD plays_VBZ a_DT role_NN in_IN neutrophil_NN trafficking_NN in_IN
        inflammation_NN ,_, although_IN neutrophil_NN trafficking_NN was_VBD
        previously_RB believed_VBN to_TO be_VB regulated_VBN only_RB by_IN IL-_NNP 8_CD ,_, and_CC not_RB
        by_IN MCP-_NNP 1_CD [_NN 26_CD ]_NN ._. These_DT previous_JJ results_NNS ,_, together_RB with_IN the_DT
        current_JJ data_NN ,_, indicate_VBP that_IN both_DT MCP-_NNP 1_CD and_CC IL-_NNP 8_CD play_VB major_JJ
        roles_NNS in_IN regulating_VBG the_DT trafficking_NN of_IN myeloid_NN cells_NNS into_IN
        inflammatory_JJ sites_NNS ._.
        The_DT role_NN of_IN specific_JJ chemokines_NNS in_IN arthritis_NN is_VBZ still_RB
        controversial_JJ ,_, and_CC further_JJ investigation_NN is_VBZ necessary_JJ to_TO
        delineate_NN to_TO specific_JJ roles_NNS of_IN these_DT effector_NN molecules_NNS ._.
        Moreover_RB ,_, the_DT role_NN of_IN tissue_NN cells_NNS in_IN regulating_VBG the_DT
        migration_NN of_IN inflammatory_JJ cells_NNS into_IN the_DT synovium_NN is_VBZ also_RB
        not_RB fully_RB established_VBN ._. The_DT current_JJ data_NN ,_, however_RB ,_, strongly_RB
        imply_VBP that_DT monocyte_NN accumulation_NN in_IN rheumatoid_NN synovium_NN is_VBZ
        regulated_VBN by_IN SCL_NNP via_IN production_NN of_IN the_DT chemokines_NNS MCP-_NNP 1_CD and_CC
        IL-_NNP 8_CD ._.
      
      
        Abbreviations_NNP
        ELISA_NNP =_SYM enzyme-linked_JJ immunosorbent_NN assay_NN ;_: IP-_NNP 10_CD =_SYM
        interferon-gamma_JJ inducible_JJ protein_NN 10_CD ;_: mAb_NN =_SYM monoclonal_NN
        antibody_NN ;_: MCP-_NNP 1_CD =_SYM monocytechemotactic_JJ protein-_NN 1_CD ;_: MIP_NNP =_SYM
        macrophage_NN inflammatory_JJ protein_NN ;_: OA_NNP =_SYM osteoarthritis_NNS ;_: PBMC_NNP
        =_SYM peripheral_JJ blood_NN mononuclear_NN cells_NNS ;_: PE_NNP =_SYM phycoerythrin_NN ;_: RA_NNP
        =_SYM rheumatoid_NN arthritis_NN ;_: RANTES_NNP =_SYM regulated_VBN upon_IN activation_NN ,_,
        normal_JJ T_NN cell_NN expressed_VBD and_CC secreted_JJ ;_: RT-PCR_NNP =_SYM reverse_VB
        transcriptase-polymerasechain_JJ reaction_NN ;_: SCL_NNP =_SYM stromal_NN cell_NN
        line_NN ;_: SRBC_NNP =_SYM sheep_NN red_JJ blood_NN cells_NNS ;_: TNF-α_NNP =_SYM tumor_NN necrosis_NNS
        factor-α_JJ ._.
      
    
  
